Back to Journals » Drug Design, Development and Therapy » Volume 9

A perspective on the benefit-risk assessment for new and emerging pharmaceuticals in Japan

Total article views   Abstract views HTML views PDF downloads Totals
10,760 Dovepress* 6,689 2,044+ 1,752 8,733
PubMed Central* 0 2,027 399 2,027
Totals 6,689 4,071 2,151 10,760
*Since 31 March 2015
+Since July 2016

View citations on PubMed Central and Google Scholar